15. Property, Plant and Equipment
(thousands of €) |
Land, building and building improvements |
Installation & |
Furniture, fixtures & vehicles |
Other |
Total |
|---|---|---|---|---|---|
Acquisition value |
|
|
|
|
|
|
|
|
|
|
|
On January 1, 2024 |
90,705 |
39,678 |
9,353 |
6,770 |
146,507 |
Additions |
7,292 |
9,595 |
118 |
298 |
17,303 |
Sales and disposals |
(6,554) |
(663) |
(2,460) |
|
(9,677) |
Reclassifications |
4,687 |
470 |
466 |
(5,623) |
– |
Reclassifications to assets in disposal group classified as held for sale |
(10,200) |
|
|
(915) |
(11,115) |
Translation differences |
84 |
204 |
(15) |
|
273 |
On December 31, 2024 |
86,014 |
49,284 |
7,462 |
530 |
143,291 |
Additions |
1,622 |
10,788 |
18 |
|
12,428 |
Sales and disposals |
(758) |
(29,284) |
(1,495) |
|
(31,537) |
Reclassifications |
(1,283) |
1,813 |
|
(530) |
– |
Translation differences |
(606) |
(667) |
(1) |
|
(1,274) |
On December 31, 2025 |
84,989 |
31,934 |
5,984 |
– |
122,908 |
|
|
|
|
|
|
Depreciation and impairment |
|
|
|
|
|
|
|
|
|
|
|
On January 1, 2024 |
11,218 |
19,178 |
4,891 |
– |
35,287 |
Depreciations |
5,284 |
4,787 |
1,005 |
|
11,076 |
Impairment |
1,068 |
17 |
158 |
|
1,243 |
Sales and disposals |
(6,554) |
(663) |
(2,460) |
|
(9,677) |
Translation differences |
(68) |
39 |
(8) |
|
(37) |
On December 31, 2024 |
10,948 |
23,358 |
3,586 |
– |
37,892 |
Depreciations |
4,021 |
5,562 |
768 |
|
10,351 |
Impairment |
4,155 |
27,900 |
661 |
|
32,716 |
Sales and disposals |
(758) |
(27,205) |
(1,485) |
|
(29,448) |
Translation differences |
(203) |
(345) |
(1) |
|
(549) |
On December 31, 2025 |
18,163 |
29,270 |
3,530 |
– |
50,962 |
|
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
|
|
|
|
On December 31, 2024 |
75,066 |
25,926 |
3,876 |
530 |
105,399 |
On December 31, 2025 |
66,826 |
2,664 |
2,455 |
– |
71,946 |
As a result of the announced wind-down of our cell therapy activities and the planned closure of sites, we recorded in 2025 an impairment on lab equipment of €19.4 million, on leasehold improvements of €3.6 million and on other assets of €0.1 million. We additionally recorded an impairment of €9.6 million on the assets related to the small molecules business.
As we signed a share purchase agreement for the construction project in Mechelen (Belgium) in December 2024, we reclassified the land and other tangible assets of Galapagos Real Estate Belgium BV to assets in disposal group classified as held for sale at December 31, 2024.
(thousands of €) |
Land & |
Installation & |
Furniture, |
Total |
|---|---|---|---|---|
Acquisition value |
|
|
|
|
|
|
|
|
|
On January 1, 2024 |
23,174 |
251 |
7,652 |
31,078 |
Additions |
4,287 |
1,657 |
2,879 |
8,823 |
Sales and disposals |
(2,989) |
(250) |
(4,114) |
(7,353) |
Translation differences |
113 |
|
|
113 |
On December 31, 2024 |
24,585 |
1,658 |
6,417 |
32,661 |
Additions |
2,181 |
|
526 |
2,707 |
Sales and disposals |
(12,023) |
(459) |
(4,962) |
(17,444) |
Translation differences |
(549) |
|
|
(549) |
On December 31, 2025 |
14,194 |
1,199 |
1,981 |
17,375 |
|
|
|
|
|
Depreciation and impairment |
|
|
|
|
|
|
|
|
|
On January 1, 2024 |
11,279 |
223 |
4,473 |
15,976 |
Depreciations |
2,848 |
118 |
1,592 |
4,558 |
Sales and disposals |
(1,920) |
(250) |
(3,200) |
(5,370) |
Translation differences |
(3) |
|
|
(3) |
On December 31, 2024 |
12,204 |
91 |
2,865 |
15,161 |
Depreciations |
2,185 |
381 |
1,351 |
3,917 |
Impairment |
3,655 |
|
|
3,655 |
Sales and disposals |
(10,811) |
(145) |
(2,890) |
(13,846) |
Translation differences |
(229) |
|
|
(229) |
On December 31, 2025 |
7,004 |
327 |
1,326 |
8,658 |
|
|
|
|
|
Carrying amount |
|
|
|
|
|
|
|
|
|
On December 31, 2024 |
12,381 |
1,567 |
3,552 |
17,499 |
On December 31, 2025 |
7,190 |
872 |
655 |
8,717 |
|
December 31 |
|
|---|---|---|
(thousands of €) |
2025 |
2024 |
Property, plant and equipment fully owned |
71,946 |
105,399 |
Right-of-use |
8,717 |
17,499 |
Total property, plant and equipment |
80,663 |
122,898 |
We recorded in 2025 an impairment on the right of use assets related to the leased buildings in Princeton and Pittsburgh (U.S.), as these sites will be closed as a result of the wind-down. The sales and disposals of 2025 and 2024 mainly relate to the disposal of leased cars.
We refer to note 26 “Lease liabilities” for a detail of the lease liabilities related to these right-of-use assets.
There are no pledged items of property, plant and equipment. There are also no restrictions in use on any items of property, plant and equipment.